Reliability and Validity of the Selective Control of the Upper Extremity Scale in Stroke Patients
Condition: Stroke
MeSH terms: Stroke
Study type: Observational

Summary: 
      Selective motor control is defined as the ability to perform the movement in isolation
      without revealing movement in another joint, without mirror movements, without using a flexor
      or extensor pattern in the extremities during a desired movement in one joint. Evaluation of
      selective motor control is important to predict future functional status in adult stroke
      patients. The Fugl-Meyer Upper Extremity Motor Rating Scale is the basic test in the
      assessment of motor functions in stroke patients. However, this test is a complicated scale
      and it takes more than one hour to complete the rating of the patient; Physicians without
      experience cannot perform the test because it is difficult. This planned study aims to
      demonstrate the validity and reliability of Selective Control of the Upper Extremity Scale
      (SCUES) in the evaluation of selective motor control of upper extremity in stroke patients;
      thus, it aims to present SCUES to medical professionals as a practical clinical tool to be
      used in stroke.
    

Detailed description: 
      According to the definition of the World Health Organization, stroke is a clinical syndrome
      characterized by rapid localization of the signs and symptoms of focal cerebral function loss
      for no apparent reason other than vascular causes, and the findings last longer than 24
      hours. It is the second leading cause of death in the world. and is one of the most common
      causes of adult-onset disability.

      Motor Control is defined as the ability to regulate or direct the mechanisms and systems
      necessary for the realization of movement. Coordinated contraction and relaxation of muscle
      groups in humans is accomplished by both reflex mechanisms and higher brain centers that
      manage functions.

      Selective motor control is defined as the ability to perform the movement in isolation
      without revealing movement in another joint, without mirror movements, without using a flexor
      or extensor pattern in the extremities, during a desired movement in one joint. Selective
      motor control skill is responsible for agile and independent movement and control of the
      joints. Evaluation of selective motor control is important to predict future functional
      status in adult stroke patients.

      Motor impairment in stroke; Tone, strength, coordination and balance should be evaluated with
      examinations. Scales such as Fugl-Meyer Upper Extremity Motor Evaluation Scale, Motor
      Evaluation Scale, Motricity index are frequently used for motor functions. The Fugl-Meyer
      Upper Extremity Motor Rating Scale is the basic test in the evaluation of motor functions in
      stroke patients. However, this test is a complicated scale and it takes more than one hour to
      complete the evaluation of the patient; Physicians without experience cannot perform the test
      because it is difficult. In conclusion, the Fugl-Meyer Upper Extremity Motor Rating Scale is
      administered by a small number of clinicians. However, evaluation of selective motor control
      in stroke is important both for the functional prognosis of the patient and for deciding on
      treatment interventions.

      The Upper Extremity Selective Control Scale (SCUES) was developed to evaluate selective motor
      control in patients with cerebral palsy, a pathology of the central nervous system such as
      stroke. It is a practical and short-term test with proven validity and reliability in the
      pediatric population with cerebral palsy.

      This planned study aims to demonstrate the validity and reliability of SCUES in the
      evaluation of selective motor control in stroke patients; thus, it aims to present SCUES to
      medical professionals as a practical clinical tool to be used in stroke.
    

Observational model: Case-Only
Time perspective: Prospective
Sampling method: Probability Sample
Study population: 
        Patients with a diagnosis of hemiplegia as a result of ischemic or hemorrhagic stroke
        documented by cranial CT or MRI, followed for at least 6 months, aged between 18-75 years,
        with upper extremity involvement and their Brunnstrom upper extremity staging is in
        between1-6.